TY - JOUR AU - F Lefrere, AU - A Delmer, AU - V Levy, AU - R Delarue, AU - B Varet, AU - O Hermine, PY - 2004/10/01 Y2 - 2024/03/29 TI - Sequential chemotherapy regimens followed by high-dose therapy with stem cell transplantation in mantle cell lymphoma: an update of a prospective study JF - Haematologica JA - haematol VL - 89 IS - 10 SE - Clinical Trial DO - 10.3324/%x UR - https://haematologica.org/article/view/3267 SP - 1275-1276 AB - This study is a long-term follow-up analysis evaluating clinical outcome of patients with mantle-cell lymphoma treated by the sequential CHOP and DHAP chemotherapy followed by autografting. The median overall survival of 81 months (95% CI, 66-not reached) and the median event free survival of 51 months (95% CI, 43-not reached) confirm the improvement in outcome obtained by such protocol. ER -